Document is current
Any future updates will be listed below
-
Authors
Sapre, Manali
Tremblay, Douglas
Wilck, Eric
James, Annie
Leiter, Amanda
Coltoff, Alexander
Koshy, Anita G.
Kremyanskaya, Marina
Hoffman, Ronald
Mascarenhas, John O.
Gallagher, Emily J. http://orcid.org/0000-0002-7920-8474
-
Funding
Funding for this research was provided by:
American Society of Hematology
- License Information
-
More Information
Article History
Received: 6 June 2019
Accepted: 26 October 2019
First Online: 12 November 2019
Competing interests
: J.O.M. has received research funding from Incyte, Novartis, Roche, Merck, CTI Biopharma, Janssen, PharmaEssentia, and is on the clinical trial steering committee for Incyte, CTI Biopharma and Celgene. M.K. has received research funding from Incyte, Constellation, Celgene, Blueprint and fees from La Jolla Pharmaceuticals. M.S., A.C., A.L., D.T., A.J., E.W. and A.G. have no conflicts of interest. E.J.G. served on advisory board for Novartis.
